Yeung Rosanna, Conroy Leigh, Long Karen, Walrath Daphne, Li Haocheng, Smith Wendy, Hudson Alana, Phan Tien
Division of Radiation Oncology, Department of Oncology, University of Calgary,, 2500 University Dr NW, Calgary, Alberta, T2N 1 N4, Canada.
Department of Medical Physics, Tom Baker Cancer Centre, 1331 29 Street Northwest, Calgary, AB, T2N 4 N2, Canada.
Radiat Oncol. 2015 Sep 22;10:200. doi: 10.1186/s13014-015-0511-8.
Deep inspiration breath hold (DIBH) reduces heart and left anterior descending artery (LAD) dose during left-sided breast radiation therapy (RT); however there is limited information about which patients derive the most benefit from DIBH. The primary objective of this study was to determine which patients benefit the most from DIBH by comparing percent reduction in mean cardiac dose conferred by DIBH for patients treated with whole breast RT ± boost (WBRT) versus those receiving breast/chest wall plus regional nodal irradiation, including internal mammary chain (IMC) nodes (B/CWRT + RNI) using a modified wide tangent technique. A secondary objective was to determine if DIBH was required to meet a proposed heart dose constraint of Dmean < 4 Gy in these two cohorts.
Twenty consecutive patients underwent CT simulation both free breathing (FB) and DIBH. Patients were grouped into two cohorts: WBRT (n = 11) and B/CWRT + RNI (n = 9). 3D-conformal plans were developed and FB was compared to DIBH for each cohort using Wilcoxon signed-rank tests for continuous variables and McNemar's test for discrete variables. The percent relative reduction conferred by DIBH in mean heart and LAD dose, as well as lung V20 were compared between the two cohorts using Wilcox rank-sum testing. The significance level was set at 0.05 with Bonferroni correction for multiple testing.
All patients had comparable target coverage on DIBH and FB. DIBH statistically significantly reduced mean heart and LAD dose for both cohorts. Percent reduction in mean heart and LAD dose with DIBH was significantly larger in the B/CWRT + RNI cohort compared to WBRT group (relative reduction in mean heart and LAD dose: 55.9 % and 72.1 % versus 29.2 % and 43.5 %, p < 0.02). All patients in the WBRT group and five patients (56 %) in the B/CWBRT + RNI group met heart Dmean <4 Gy with FB. All patients met this constraint with DIBH.
All patients receiving WBRT met Dmean Heart < 4 Gy on FB, while only slightly over half of patients receiving B/CWRT + RNI were able to meet this constraint in FB. DIBH allowed a greater reduction in mean heart and LAD dose in patients receiving B/CWRT + RNI, including IMC nodes than patients receiving WBRT. These findings suggest greatest benefit from DIBH treatment for patients receiving regional nodal irradiation.
深吸气屏气(DIBH)可降低左侧乳腺癌放疗(RT)期间心脏和左前降支动脉(LAD)的剂量;然而,关于哪些患者从DIBH中获益最大的信息有限。本研究的主要目的是通过比较接受全乳放疗±瘤床加量(WBRT)的患者与接受乳腺/胸壁加区域淋巴结照射(包括内乳链(IMC)淋巴结)(B/CWRT + RNI)并采用改良大切线技术的患者,DIBH使平均心脏剂量降低的百分比,来确定哪些患者从DIBH中获益最大。次要目的是确定在这两个队列中是否需要DIBH来满足提议的心脏剂量约束Dmean < 4 Gy。
连续20例患者在自由呼吸(FB)和DIBH状态下进行CT模拟。患者分为两个队列:WBRT(n = 11)和B/CWRT + RNI(n = 9)。制定三维适形计划,对于每个队列,使用Wilcoxon符号秩检验比较连续变量的FB和DIBH,使用McNemar检验比较离散变量。使用Wilcox秩和检验比较两个队列中DIBH使平均心脏和LAD剂量降低的百分比以及肺V20。显著性水平设定为0.05,并采用Bonferroni校正进行多重检验。
所有患者在DIBH和FB状态下的靶区覆盖情况相当。DIBH在统计学上显著降低了两个队列的平均心脏和LAD剂量。与WBRT组相比,B/CWRT + RNI队列中DIBH使平均心脏和LAD剂量降低的百分比显著更大(平均心脏和LAD剂量的相对降低:55.9%和72.1%,而WBRT组为29.2%和43.5%,p < 0.02)。WBRT组的所有患者以及B/CWBRT + RNI组的5例患者(56%)在FB状态下达到心脏Dmean < 4 Gy。所有患者在DIBH状态下均满足该约束。
所有接受WBRT的患者在FB状态下达到Dmean心脏< 4 Gy,而接受B/CWRT + RNI的患者中只有略超过一半在FB状态下能够满足该约束。与接受WBRT的患者相比,DIBH使接受B/CWRT + RNI(包括IMC淋巴结)的患者的平均心脏和LAD剂量有更大程度的降低。这些发现表明,接受区域淋巴结照射的患者从DIBH治疗中获益最大。